Finoriq research workspace
NOVO NORDISK A S (NVO) Institutional Holdings & 13F Ownership
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of. Review NVO institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
- Company
- NOVO NORDISK A S (NVO)
- Ticker
- NVO
- Market Cap
- $219.9B
- Latest Price
- $49.67
- Industry
- Biotech & Pharma
NOVO NORDISK A S (NVO) Top Institutional Holders
Top current 13F holders indexed for NOVO NORDISK A S (NVO). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Dodge & Cox (advisor level)CIK 0000200217 | $710.5M | 0.39% | Filing2026-05-14 |
| 2 | Ken FisherCIK 0000850529 | $331.5M | 0.11% | Filing2026-05-05 |
| 3 | Thomas GaynerCIK 0001096343 | $105.5M | 0.88% | Filing2026-05-01 |
| 4 | Lee AinslieCIK 0000934639 | $76.4M | 0.88% | Filing2026-05-15 |
| 5 | Sarah KettererCIK 0001165797 | $43.2M | 0.53% | Filing2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.